{"id":4186,"date":"2018-04-05T11:52:16","date_gmt":"2018-04-05T15:52:16","guid":{"rendered":"http:\/\/www.imperialcrs.com\/blog\/?p=4186"},"modified":"2023-12-12T17:00:04","modified_gmt":"2023-12-12T17:00:04","slug":"surviving-the-transition-into-clinical-trials-getting-started","status":"publish","type":"post","link":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/","title":{"rendered":"Surviving the Transition Into Clinical Trials: Getting Started"},"content":{"rendered":"<p>We recently held the second of our presentation series \u201cSurviving the Transition to Clinical Trials\u201d at <a href=\"https:\/\/jlabs.jnjinnovation.com\/\">JLABS<\/a> in Toronto.<\/p>\n<p>More than 45 people, representing biotech, pharma, and medical device companies, came to find out how to take their innovative ideas from the lab to the clinic. Speaker Melynda Geurts, Imperial\u2019s global director of patient engagement, emphasized that proactive planning, rather than reactive planning, is critical to recruiting and retaining patients, and containing costs.<\/p>\n<p>The rapidly growing clinical research business is open to aspiring entrepreneurs who have innovative ideas. This industry is highly profitable but dependent on the ability to come up with breakthrough clinical research. To ensure success, you need to carry out thorough feasibility studies and market surveys. Strategic planning is an important step that you should not take for granted when launching your own clinical research business.<\/p>\n<p>Before starting your first clinical trial, Melynda recommends:<\/p>\n<ul>\n<li>Get an overview of the industry; analyze market trends and threats<\/li>\n<li>Write an executive summary that includes:\n<ul>\n<li>Your services or vision<\/li>\n<li>A mission statement<\/li>\n<li>Structure of the business<\/li>\n<li>Roles and responsibilities<\/li>\n<li>Your target market<\/li>\n<li>Your competitive advantage<\/li>\n<li>Startup expenditures<\/li>\n<li>Sources of income<\/li>\n<li>Sales forecast<\/li>\n<li>A checklist of milestones<\/li>\n<\/ul>\n<\/li>\n<li>Establish business relationships with pharmaceutical and biomedical companies, key stakeholders, and other essential partners<\/li>\n<\/ul>\n<p>Proactive planning can help you enter the clinic successfully and reach your goals. Being aware of potential hurdles and developing strategies to deal with them can save you considerable time and money.<\/p>\n<p>View our other blogs related to Melynda&#8217;s presentation at JLABS<\/p>\n<p><a href=\"https:\/\/www.imperialcrs.com\/blog\/2018\/02\/outsmartbigdogs\/\">3 Ways to Outsmart the Big Dogs as you Move to Clinic<\/a><\/p>\n<p><a href=\"https:\/\/www.imperialcrs.com\/blog\/2018\/01\/lab_to_clinic\/\">The Role of Patient Engagement in the Transition from Lab to Clinic<\/a><\/p>\n<p>PC: JLABS Innovation<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We recently held the second of our presentation series \u201cSurviving the Transition to Clinical Trials\u201d at JLABS in Toronto. More than 45 people, representing biotech, pharma, and medical device companies, came to find out how to take their innovative ideas from the lab to the&hellip;<\/p>\n","protected":false},"author":15,"featured_media":4195,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[22,43],"tags":[1514,1515,1517,677,1510,50,1512,1513,1511,1516],"class_list":["post-4186","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-insights","category-events","tag-clinical-study-launch","tag-clinical-trial-beginners","tag-clinical-trial-implementation","tag-clinical-trial-preparation","tag-clinical-trial-start","tag-clinical-trials","tag-research-initiation","tag-research-transition","tag-transition-to-clinical-research","tag-trial-onboarding"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Surviving the Transition Into Clinical Trials: Getting Started<\/title>\n<meta name=\"description\" content=\"More than 45 people, representing biotech, pharma, and medical device companies, came to find out how to take their innovative ideas from the lab to the clinic. Speaker Melynda Geurts, emphasized that proactive is critical to recruiting and retaining patients, and containing costs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Surviving the Transition Into Clinical Trials: Getting Started\" \/>\n<meta property=\"og:description\" content=\"More than 45 people, representing biotech, pharma, and medical device companies, came to find out how to take their innovative ideas from the lab to the clinic. Speaker Melynda Geurts, emphasized that proactive is critical to recruiting and retaining patients, and containing costs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/\" \/>\n<meta property=\"og:site_name\" content=\"Imperial Clinical Research Services Blog\" \/>\n<meta property=\"article:published_time\" content=\"2018-04-05T15:52:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-12T17:00:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2018\/04\/Jlabs-Toronto-scaled-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1507\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Hope Cullen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Hope Cullen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/surviving-the-transition-into-clinical-trials-getting-started\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/surviving-the-transition-into-clinical-trials-getting-started\\\/\"},\"author\":{\"name\":\"Hope Cullen\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/f5ea4756270af4e61cd5b2f9624a9907\"},\"headline\":\"Surviving the Transition Into Clinical Trials: Getting Started\",\"datePublished\":\"2018-04-05T15:52:16+00:00\",\"dateModified\":\"2023-12-12T17:00:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/surviving-the-transition-into-clinical-trials-getting-started\\\/\"},\"wordCount\":286,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/surviving-the-transition-into-clinical-trials-getting-started\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/Jlabs-Toronto-scaled-1.jpg\",\"keywords\":[\"Clinical Study Launch\",\"Clinical Trial Beginners\",\"Clinical Trial Implementation\",\"Clinical Trial Preparation\",\"Clinical Trial Start\",\"Clinical Trials\",\"Research Initiation\",\"Research Transition\",\"Transition to Clinical Research\",\"Trial Onboarding\"],\"articleSection\":[\"Business Insights\",\"Life-Science Events\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/surviving-the-transition-into-clinical-trials-getting-started\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/surviving-the-transition-into-clinical-trials-getting-started\\\/\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/surviving-the-transition-into-clinical-trials-getting-started\\\/\",\"name\":\"Surviving the Transition Into Clinical Trials: Getting Started\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/surviving-the-transition-into-clinical-trials-getting-started\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/surviving-the-transition-into-clinical-trials-getting-started\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/Jlabs-Toronto-scaled-1.jpg\",\"datePublished\":\"2018-04-05T15:52:16+00:00\",\"dateModified\":\"2023-12-12T17:00:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/f5ea4756270af4e61cd5b2f9624a9907\"},\"description\":\"More than 45 people, representing biotech, pharma, and medical device companies, came to find out how to take their innovative ideas from the lab to the clinic. Speaker Melynda Geurts, emphasized that proactive is critical to recruiting and retaining patients, and containing costs.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/surviving-the-transition-into-clinical-trials-getting-started\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/surviving-the-transition-into-clinical-trials-getting-started\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/surviving-the-transition-into-clinical-trials-getting-started\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/Jlabs-Toronto-scaled-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/Jlabs-Toronto-scaled-1.jpg\",\"width\":2560,\"height\":1507},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/business-insights\\\/surviving-the-transition-into-clinical-trials-getting-started\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Surviving the Transition Into Clinical Trials: Getting Started\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/\",\"name\":\"Imperial Clinical Research Services Blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/f5ea4756270af4e61cd5b2f9624a9907\",\"name\":\"Hope Cullen\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/95283400932bb2ba8a9c319f1e68c46a5d7b01869610a28fa8233a1e6c7bde70?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/95283400932bb2ba8a9c319f1e68c46a5d7b01869610a28fa8233a1e6c7bde70?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/95283400932bb2ba8a9c319f1e68c46a5d7b01869610a28fa8233a1e6c7bde70?s=96&d=mm&r=g\",\"caption\":\"Hope Cullen\"},\"description\":\"Hope is director of project operations, Imperial Clinical Research Services. She has been with Imperial since 2007, and started as a project manager. In her current role, she leads a team of 11 project managers and coordinators to provide production, procurement, assembly, and logistics services for client study materials in support of global clinical trials. She also oversees client interaction, workload management, work processes and improvements, and revenue growth through customer service and relationship development efforts.\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/author\\\/hcullen\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Surviving the Transition Into Clinical Trials: Getting Started","description":"More than 45 people, representing biotech, pharma, and medical device companies, came to find out how to take their innovative ideas from the lab to the clinic. Speaker Melynda Geurts, emphasized that proactive is critical to recruiting and retaining patients, and containing costs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/","og_locale":"en_US","og_type":"article","og_title":"Surviving the Transition Into Clinical Trials: Getting Started","og_description":"More than 45 people, representing biotech, pharma, and medical device companies, came to find out how to take their innovative ideas from the lab to the clinic. Speaker Melynda Geurts, emphasized that proactive is critical to recruiting and retaining patients, and containing costs.","og_url":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/","og_site_name":"Imperial Clinical Research Services Blog","article_published_time":"2018-04-05T15:52:16+00:00","article_modified_time":"2023-12-12T17:00:04+00:00","og_image":[{"width":2560,"height":1507,"url":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2018\/04\/Jlabs-Toronto-scaled-1.jpg","type":"image\/jpeg"}],"author":"Hope Cullen","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Hope Cullen","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/#article","isPartOf":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/"},"author":{"name":"Hope Cullen","@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/f5ea4756270af4e61cd5b2f9624a9907"},"headline":"Surviving the Transition Into Clinical Trials: Getting Started","datePublished":"2018-04-05T15:52:16+00:00","dateModified":"2023-12-12T17:00:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/"},"wordCount":286,"commentCount":0,"image":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/#primaryimage"},"thumbnailUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2018\/04\/Jlabs-Toronto-scaled-1.jpg","keywords":["Clinical Study Launch","Clinical Trial Beginners","Clinical Trial Implementation","Clinical Trial Preparation","Clinical Trial Start","Clinical Trials","Research Initiation","Research Transition","Transition to Clinical Research","Trial Onboarding"],"articleSection":["Business Insights","Life-Science Events"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/","url":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/","name":"Surviving the Transition Into Clinical Trials: Getting Started","isPartOf":{"@id":"https:\/\/www.imperialcrs.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/#primaryimage"},"image":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/#primaryimage"},"thumbnailUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2018\/04\/Jlabs-Toronto-scaled-1.jpg","datePublished":"2018-04-05T15:52:16+00:00","dateModified":"2023-12-12T17:00:04+00:00","author":{"@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/f5ea4756270af4e61cd5b2f9624a9907"},"description":"More than 45 people, representing biotech, pharma, and medical device companies, came to find out how to take their innovative ideas from the lab to the clinic. Speaker Melynda Geurts, emphasized that proactive is critical to recruiting and retaining patients, and containing costs.","breadcrumb":{"@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/#primaryimage","url":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2018\/04\/Jlabs-Toronto-scaled-1.jpg","contentUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2018\/04\/Jlabs-Toronto-scaled-1.jpg","width":2560,"height":1507},{"@type":"BreadcrumbList","@id":"https:\/\/www.imperialcrs.com\/blog\/business-insights\/surviving-the-transition-into-clinical-trials-getting-started\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.imperialcrs.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Surviving the Transition Into Clinical Trials: Getting Started"}]},{"@type":"WebSite","@id":"https:\/\/www.imperialcrs.com\/blog\/#website","url":"https:\/\/www.imperialcrs.com\/blog\/","name":"Imperial Clinical Research Services Blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.imperialcrs.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/f5ea4756270af4e61cd5b2f9624a9907","name":"Hope Cullen","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/95283400932bb2ba8a9c319f1e68c46a5d7b01869610a28fa8233a1e6c7bde70?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/95283400932bb2ba8a9c319f1e68c46a5d7b01869610a28fa8233a1e6c7bde70?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/95283400932bb2ba8a9c319f1e68c46a5d7b01869610a28fa8233a1e6c7bde70?s=96&d=mm&r=g","caption":"Hope Cullen"},"description":"Hope is director of project operations, Imperial Clinical Research Services. She has been with Imperial since 2007, and started as a project manager. In her current role, she leads a team of 11 project managers and coordinators to provide production, procurement, assembly, and logistics services for client study materials in support of global clinical trials. She also oversees client interaction, workload management, work processes and improvements, and revenue growth through customer service and relationship development efforts.","url":"https:\/\/www.imperialcrs.com\/blog\/author\/hcullen\/"}]}},"_links":{"self":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/4186","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/comments?post=4186"}],"version-history":[{"count":1,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/4186\/revisions"}],"predecessor-version":[{"id":70754,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/4186\/revisions\/70754"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/media\/4195"}],"wp:attachment":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/media?parent=4186"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/categories?post=4186"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/tags?post=4186"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}